Trials / Sponsors / Sally E. Wenzel MD
Sally E. Wenzel MD
Academic / Other · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma | Phase 4 | 2022-10-17 |
| Completed | Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma Asthma, Severe Persistent Asthma | — | 2013-01-01 |
| Completed | Electrophilic Fatty Acid Derivatives in Asthma Asthma, Electrophilic Fatty Acids | Phase 1 | 2011-10-01 |
| Withdrawn | Anti-Inflammatory Lipid Mediators in Asthma Asthma | Phase 2 | — |
| Approved For Marketing | Dupilumab Compassionate Use Study Asthma | — | — |